Product
NanoPac®
1 clinical trial
1 indication
Indication
Pancreatic CancerClinical trial
Phase IIa Trial Evaluating the Safety of Intratumoral Injection of NanoPac® in Subjects With Locally Advanced Pancreatic AdenocarcinomaStatus: Completed, Estimated PCD: 2023-03-15